In a similar manner, the serum butyrylcholinesterase, another low-cost biomarker, has been used in colorectal surgery patients, with decreased levels of this biomarker in patients undergoing colorectal surgery with surgical site infection and high prognostic significance in the development of septic complications [22,23]. The gene discussed is BCHE; the disease is infection.